CIRCULATORY FAILURE NEONATAL

CIRCULATORY FAILURE NEONATAL was reported 59 times

CIRCULATORY FAILURE NEONATAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Surfactant [EPC] 1 0.0009
1 Lipid Emulsion [EPC] 1 0.0004
2 Monobactam Antibacterial [EPC] 1 0.0004
3 Oxytocic [EPC] 1 0.0003
4 Echinocandin Antifungal [EPC] 1 0.0001
5 Prostaglandin E1 Analog [EPC] 2 0.0001
6 Parenteral Iron Replacement [EPC] 1 0.0001
7 Penem Antibacterial [EPC] 2 0.0001
8 General Anesthetic [EPC] 2 0.0000
9 Glycopeptide Antibacterial [EPC] 3 0.0000
10 Insulin [EPC] 2 0.0000
11 Progesterone [EPC] 1 0.0000
12 Methylxanthine [EPC] 2 0.0000
13 CD20-directed Cytolytic Antibody [EPC] 10 0.0000
14 Cardiac Glycoside [EPC] 2 0.0000
15 Aldosterone Antagonist [EPC] 4 0.0000
16 Catecholamine [EPC] 2 0.0000
17 Central Nervous System Stimulant [EPC] 2 0.0000
18 Aminoglycoside Antibacterial [EPC] 1 0.0000
19 Macrolide Antimicrobial [EPC] 1 0.0000
20 Loop Diuretic [EPC] 8 0.0000
21 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
22 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
23 Atypical Antipsychotic [EPC] 7 0.0000
24 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
25 Azole Antifungal [EPC] 2 0.0000
26 Aromatase Inhibitor [EPC] 1 0.0000
27 Alkylating Drug [EPC] 2 0.0000
28 Fluoroquinolone Antibacterial [EPC] 1 0.0000
29 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
30 Corticosteroid [EPC] 9 0.0000
31 Vitamin B12 [EPC] 2 0.0000
32 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
33 Estrogen [EPC] 1 0.0000
34 Kinase Inhibitor [EPC] 2 0.0000
35 Osmotic Laxative [EPC] 1 0.0000
36 Vitamin D [EPC] 1 0.0000
37 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
38 Vitamin C [EPC] 1 0.0000
39 Platelet Aggregation Inhibitor [EPC] 1 0.0000
40 Proton Pump Inhibitor [EPC] 1 0.0000
41 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000